Craig Hettenbach
Stock Analyst at Morgan Stanley
(2.16)
# 2,668
Out of 4,784 analysts
288
Total ratings
56.72%
Success rate
-1.59%
Average return
Main Sectors:
Stocks Rated by Craig Hettenbach
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UHS Universal Health Services | Initiates: Equal-Weight | $200 | $186.18 | +7.42% | 1 | Mar 26, 2025 | |
| THC Tenet Healthcare | Initiates: Overweight | $165 | $133.14 | +23.93% | 1 | Mar 26, 2025 | |
| VEEV Veeva Systems | Maintains: Underweight | $195 → $201 | $234.21 | -14.18% | 7 | Mar 6, 2025 | |
| HIMS Hims & Hers Health | Downgrades: Equal-Weight | $42 → $60 | $29.14 | +105.90% | 2 | Feb 18, 2025 | |
| ARDT Ardent Health Partners | Maintains: Overweight | $24 → $22 | $13.20 | +66.67% | 2 | Jan 21, 2025 | |
| AMWL American Well | Maintains: Equal-Weight | $20 → $11 | $7.82 | +34.27% | 5 | Dec 17, 2024 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $7 → $6 | $4.50 | +33.33% | 2 | Dec 17, 2024 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $406 → $355 | $342.16 | +3.75% | 2 | Dec 17, 2024 | |
| SLAB Silicon Laboratories | Maintains: Equal-Weight | $123 → $97 | $113.03 | -14.18% | 14 | Nov 5, 2024 | |
| DH Definitive Healthcare | Maintains: Equal-Weight | $9 → $5 | $2.94 | +70.07% | 12 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $96 → $114 | $64.12 | +77.79% | 24 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $57 | $24.75 | +130.30% | 19 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $81 | $48.70 | +66.32% | 23 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $35 | $58.51 | -40.18% | 4 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $13.30 | +35.34% | 4 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $185 | $71.50 | +158.74% | 23 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $162 → $167 | $142.13 | +17.50% | 23 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $42 | $66.59 | -36.93% | 25 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $159 | $167.33 | -4.98% | 2 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $125 | $67.14 | +86.18% | 3 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $72 | $169.12 | -57.25% | 22 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $193 → $195 | $176.33 | +10.59% | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $488 | $516.04 | -5.43% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $297 → $296 | $322.85 | -8.32% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $273 → $368 | $230.02 | +59.99% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $513 | $264.58 | +93.89% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $275 | $325.04 | -15.40% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $88 | $60.04 | +46.57% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | n/a | $40.94 | - | 11 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $185 | $63.06 | +193.37% | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $190 → $213 | $189.99 | +12.11% | 19 | Apr 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $53 → $58 | $91.80 | -36.82% | 12 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $101 → $117 | $201.56 | -41.95% | 15 | Jun 16, 2020 |
Universal Health Services
Mar 26, 2025
Initiates: Equal-Weight
Price Target: $200
Current: $186.18
Upside: +7.42%
Tenet Healthcare
Mar 26, 2025
Initiates: Overweight
Price Target: $165
Current: $133.14
Upside: +23.93%
Veeva Systems
Mar 6, 2025
Maintains: Underweight
Price Target: $195 → $201
Current: $234.21
Upside: -14.18%
Hims & Hers Health
Feb 18, 2025
Downgrades: Equal-Weight
Price Target: $42 → $60
Current: $29.14
Upside: +105.90%
Ardent Health Partners
Jan 21, 2025
Maintains: Overweight
Price Target: $24 → $22
Current: $13.20
Upside: +66.67%
American Well
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $20 → $11
Current: $7.82
Upside: +34.27%
GoodRx Holdings
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $7 → $6
Current: $4.50
Upside: +33.33%
HCA Healthcare
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $406 → $355
Current: $342.16
Upside: +3.75%
Silicon Laboratories
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $123 → $97
Current: $113.03
Upside: -14.18%
Definitive Healthcare
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $5
Current: $2.94
Upside: +70.07%
Feb 7, 2023
Maintains: Equal-Weight
Price Target: $96 → $114
Current: $64.12
Upside: +77.79%
Jun 10, 2022
Maintains: Overweight
Price Target: $62 → $57
Current: $24.75
Upside: +130.30%
Jun 10, 2022
Maintains: Overweight
Price Target: $85 → $81
Current: $48.70
Upside: +66.32%
May 18, 2022
Maintains: Equal-Weight
Price Target: $55 → $35
Current: $58.51
Upside: -40.18%
Mar 28, 2022
Maintains: Overweight
Price Target: $20 → $18
Current: $13.30
Upside: +35.34%
Feb 3, 2022
Maintains: Overweight
Price Target: $208 → $185
Current: $71.50
Upside: +158.74%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $162 → $167
Current: $142.13
Upside: +17.50%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $42 → $42
Current: $66.59
Upside: -36.93%
Dec 17, 2021
Maintains: Equal-Weight
Price Target: $165 → $159
Current: $167.33
Upside: -4.98%
Dec 13, 2021
Maintains: Overweight
Price Target: $115 → $125
Current: $67.14
Upside: +86.18%
Dec 10, 2021
Maintains: Overweight
Price Target: $57 → $72
Current: $169.12
Upside: -57.25%
Oct 27, 2021
Maintains: Underweight
Price Target: $193 → $195
Current: $176.33
Upside: +10.59%
Aug 31, 2021
Maintains: Overweight
Price Target: $515 → $488
Current: $516.04
Upside: -5.43%
Aug 31, 2021
Maintains: Overweight
Price Target: $297 → $296
Current: $322.85
Upside: -8.32%
Aug 31, 2021
Maintains: Overweight
Price Target: $273 → $368
Current: $230.02
Upside: +59.99%
Aug 31, 2021
Maintains: Overweight
Price Target: $500 → $513
Current: $264.58
Upside: +93.89%
Aug 31, 2021
Maintains: Overweight
Price Target: $321 → $275
Current: $325.04
Upside: -15.40%
Aug 31, 2021
Maintains: Overweight
Price Target: $94 → $88
Current: $60.04
Upside: +46.57%
Aug 3, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $40.94
Upside: -
May 7, 2021
Maintains: Overweight
Price Target: $173 → $185
Current: $63.06
Upside: +193.37%
Apr 8, 2021
Downgrades: Equal-Weight
Price Target: $190 → $213
Current: $189.99
Upside: +12.11%
Feb 11, 2021
Maintains: Equal-Weight
Price Target: $53 → $58
Current: $91.80
Upside: -36.82%
Jun 16, 2020
Maintains: Equal-Weight
Price Target: $101 → $117
Current: $201.56
Upside: -41.95%